McKim Workshop on Strategic Approaches for Reducing Data Redundancy in Cancer Assessment Jay R. Niemelä Technical University of Denmark National Food Institute.

Slides:



Advertisements
Similar presentations
Structure-Activity Relationships in Toxicology: Introduction (and a case study) Part I. Romualdo Benigni Istituto Superiore di Sanita Rome.
Advertisements

Group 1B: Suitable Top Concentration for Tests with Mammalian Cells -MLA Workgroup- 5 TH INTERNATIONAL WORKSHOP ON GENOTOXICITY TESTING Basle, August 17-19,
Group 6 Follow-up of in vivo positive results Follow-up of 2005 IWGT and subsequent work done by HESI IVGT on follow-up of in vitro positive results. Takes.
Evaluation of a potential mutagenic MOA based on analysis of the weight of evidence and using the modified Hill criteria Martha M. Moore, Ph.D. Director,
© FSANZ © FSANZ 2002 FUNCTIONS OF FSANZ  FSANZ is a partnership between the Australian Commonwealth,
Nonclinical Pharmacology/ Toxicology Data for PROTOPIC  (Tacrolimus ointment for Atopic Dermatitis) Barbara Hill, Ph.D. Division of Dermatologic and Dental.
June 2010 LANDSIEDEL 1 Chemical Industries Role in Tomorrows Toxicity Testing Robert Landsiedel, Susanne Kolle, Tzutzuy Ramirez, Hennicke Kamp and Ben.
Development of an Institutional Knowledge-base at FDA’s Center for Food Safety and Applied Nutrition Kirk B. Arvidson 1, Annette McCarthy 1, Chihae Yang.
IDENTIFICATION OF CHEMICALS OF CONCERN WITH RESPECT TO CARCINOGENICITY Vicki L. Dellarco, Ph.D. Office of Pesticide Programs U.S. Environmental Protection.
Emissions Transport and Fate Concentrations Exposure Dose Dose-response Relationship Health Risk Schematic overview of a Health Risk Assessment.
Principles of Occupational Toxicology 2 – Types of toxicity
NSF/ANSI STANDARD 61 FRAMEWORK FOR RISK ASSESSMENTS For use by Toxicology Sub-committee only Please do not copy or distribute.
Methods of genotoxicology
What Do Toxicologists Do?
Food and Drug Administration Preclinical safety data for “first in human” (FIH) clinical trials in healthy volunteer subjects Oncology Drug Advisory Committee.
Criteria for Screens— Review of the EDSTAC Recommendations Presentation to the EDMVS July 23, 2002.
ILSI Risk Science Institute Acrylamide Toxicity: Research to Address Key Data Gaps Presented by Dr. Stephen S. Olin ILSI Risk Science Institute.
Application of Toxicology Databases in Drug Development (Estimating potential toxicity) Joseph F. Contrera, Ph.D. Director, Regulatory Research and Analysis.
Development and Application of Computational Toxicology and Informatics Resources at the FDA CDER Office of Pharmaceutical Science The Informatics and.
An Evaluation of the Scientific Peer-Reviewed Research and Literature on the Human Health Effects of MTBE, its Metabolites, Combustion Products and Substitute.
Toxicology Component of FDA’s Action Plan for Acrylamide Richard Canady, PhD DABT US Food and Drug Administration Center for Food Safety and Applied Nutrition.
28/05/12 Questions (Rispondete alle domande che seguono usando il colore rosso per il testo) Tossicologia - Rubbiani Maristella.
* Carcinogenicity *General Toxicology **DART **Safety Pharmacology HighMedium Low Genetic Toxicity Pharmacokinetics Pharmacology Study Group Priority Study.
Cells go through two rounds of division in meiosis.
High Throughput Genotoxicity Profiling of the US EPA ToxCast TM Chemical Library S Little 1, AW Knight 2, L Birrell 2, G Akerman 3, N McCarroll 3, D Dix.
Health Canada experiences with early identification of potential carcinogens - An Existing Substances Perspective Sunil Kulkarni Hazard Methodology Division,
GENOTOXICITY AND INDUSTRY: UTILIZING GENETIC TOXICITY ASSAYS TO SUPPORT PHARMACEUTICAL DEVELOPMENT August 24, 2015 Dan Roberts, MS Research Scientist Genetic.
Furan in Food Summary and Charge to the FAC and SCNT Terry C. Troxell, Ph.D. Director Office of Plant and Dairy Foods FDA Center for Food Safety and Applied.
2 n McKim Workshop on Reducing Data Redundancy in Cancer Assessment | 8 – 10 May 2012 | Baltimore, MD Highlighting the Need for AOPs in Streamlining Hazard.
Basic Aspects and Most Commonly Worldwide Employed and Validated In Vitro Assays Leon F. Stankowski, Jr., PhD Consultant, Genetic Toxicology Genotoxicity.
CA-1 Preclinical Studies Philip Bentley, PhD Vice President Toxicology/Pathology Novartis Pharmaceuticals Corporation Philip Bentley, PhD Vice President.
Chapter 10: Chemical-Induced Mutagenesis. DNA and Mutations A mutation is a permanent change in the DNA. DNA is in our chromosomes and it codes for all.
Juan Alguacil, MD Huelva University Brussels, 26 June 2012 Limits on Occupational Exposure Limits for Carcinogens 8th Seminar on workers’ protection &
Lhasa ICH M7 Database – Use Cases Dr Angela White.
MAIN TOXICITY TESTING. TESTING STRATEGIES A number of different types of data are used in order to establish the safety of chemical substances for use.
August 24-26, 2015 Philadelphia, USA
Kamala Pant, M.S. BioReliance Study Director/Principal Scientist
GENERAL OVERVIEW OF THE COMET ASSAY AND ITS APPLICATIONS Diana Anderson University of Bradford United Kingdom.
1.Collection of relevant data – toxicity and exposure 2.Selection of critical studies and/or HCVs 3.Health risk assessment – systemic 4.Health risk assessment.
ASTM F748 Selecting Biological Test Methods
Barcelona April, 2008 Overview of the QSAR Application Toolbox Gilman Veith International QSAR Foundation Duluth, Minnesota.
1.Collection of relevant data – toxicity and exposure 2.Selection of critical studies and/or HCVs 3.Health risk assessment – systemic 4.Health risk assessment.
McKim Conference on Predictive Toxicology The Inn of Lake Superior Duluth, Minnesota September 16-18, 2008 Toxicity Pathways as an Organizing Concept Gilman.
Furan-Induced Cytotoxicity, Cell Proliferation, and Tumorgenicity in Mouse Liver Dr. Glenda Moser.
The Future of Chemical Toxicity Testing in the U.S.
Pediatric Subcommittee of the AIDAC October 29-30, Topical Immunosuppressants (Calcineurin Inhibitors) - Animal Toxicology October 30, 2003 Barbara.
QSAR in CANCER ASSESSMENT PURPOSE and AGENDA Gilman Veith Duluth MN May 19-21, 2010.
Toxic effects Acute / chronic Reversible / irreversible Immediate / delayed Idiosyncratic - hypersensitivity Local / systemic Target organs.
Responsible Officer, Volume 112 Monographs Programme
James G. Farrelly, Ph.D. Pharmacology Team Leader Division of Antiviral Drug Products Center for Drug Evaluation and Research Food and Drug Administration.
Summation of Toxicity Data in Vitic Andrew Thresher
CELL DIFFERENTIATION.
(Quantitative) Structure- Activity Relationships (Q)SAR.
QSAR Toolbox Customized search (Query Tool)
QSAR Toolbox Customized search (Query Tool)
Decision Contexts in a Changing Toxicology Paradigm
Bystander Effects.
Mitosis, Cell Cycle, Meiosis
Advisory Committee for Pharmaceutical Science (ACPS)
DNA, protein synthesis, gene expression & mutations
Mechanisms for the Diversity of Life
QSAR Toolbox Customized search (Query Tool)
Ovanes Mekenyan, Milen Todorov, Ksenia Gerova
QSAR Toolbox Customized search (Query Tool)
The Category Approach for Predicting Mutagenicity and Carcinogenicity
Chromosomes And Inheritance
Note lack of cytotoxicity
Positive Genetox Findings on a Candidate Pharmaceutical…. Now What
Human and Animal Testing: What’s Appropriate
Presentation transcript:

McKim Workshop on Strategic Approaches for Reducing Data Redundancy in Cancer Assessment Jay R. Niemelä Technical University of Denmark National Food Institute Division of Toxicology and Risk Assessment In silico methods for predicting chromosomal endpoints for carcinogens

2DTU Food, Technical University of Denmark Eva Bay Wedebye Gunde Egeskov Jensen Marianne Dybdahl Nikolai Nikolov Svava Jonsdottir Tine Ringsted

3DTU Food, Technical University of Denmark Data set: EINECS 49,292 discrete organics European Inventory of Existing Chemical Substances Very similar to U.S TSCA inventory and expected to contain most REACH chemicals.

4DTU Food, Technical University of Denmark Objective 1. To define a large set of carcinogens and non-carcinogens 2. Analyse these chemicals for genotoxic potential in a set of in vitro models 3. Further assess performance in in vivo models.

5DTU Food, Technical University of Denmark Pure In Silico Any relation to test data is incidental

6DTU Food, Technical University of Denmark Method Global (Q)SARs in between Local (Q)SARs Closely related structures Accurate predictions for a small number of chemicals Fragment rule-based Fast High throughput Diverse

7DTU Food, Technical University of Denmark Model Platform: MULTICASE Cancer models MULTICASE FDA proprietary, male and female mouse and rat MULTICASE Ashby fragments

8DTU Food, Technical University of Denmark Gentotoxicity models. Developed in-house. QMRF’s and training sets available In Vitro HGPRT forward mutation in CHO cell Mutations in mouse lymphoma Chromosomal aberration CHL Reverse mutation test, Ames SHE cell transformation In Vivo Drosophila melanogaster Sex-Linked Recessive Lethal Mutations in mouse micronucleus Dominant lethal mutations in rodent Sister chromatid exchange in mouse bone marrow COMET assay in mouse

9DTU Food, Technical University of Denmark Domaine Only predicitons with no fragment- or statistical warnings were used. For positive cancer predictions, ICSAS criteria, meaning that at least two were positive (trans-gender or trans-species) To be considerd a non-carcinogen, chemicals had to be predicted negative in all four models (MM, FM, MR, FR)

10DTU Food, Technical University of Denmark Activity distribution

11DTU Food, Technical University of Denmark Clustering actives

12DTU Food, Technical University of Denmark Structures

13DTU Food, Technical University of Denmark Activity distribution with Ashby positives removed

14DTU Food, Technical University of Denmark In vitro results for Ashby negative carcinogens AmesCAMLHGPRTUDSSHE Ames CA ML HGPRT UDS25987 SHE768

15DTU Food, Technical University of Denmark General estimates and in vitro predictions (4037) Ames test934(21.1%) Chromosomal aberrations516(12.8%) Mouse lymphoma1167(28.9%) HGPRT559(13.8%) Unscheduled DNA synthesis259(6.4%) Cell transformation (SHE)768(19.0%)

16DTU Food, Technical University of Denmark In vitro mutagens Predicted positive in Ames test, Mouse lymphoma, or Chromosomal aberrations CHL

17DTU Food, Technical University of Denmark Distribution of in vivo positives (1853) 1853 Genotoxic carcinogens Non- carcinogens Mouse micronucleus Sister chromatid exchange Comet assay Drosophila sex-linked recessive lethal77550 Rodent dominant lethal102741

18DTU Food, Technical University of Denmark Distribution of in vivo positives by percent Genotoxic carcinogens, % Non- carcinogens, % Mouse micronucleus Sister chromatid exchange Comet assay Drosophila sex-linked recessive lethal Rodent dominant lethal5.54.7

19DTU Food, Technical University of Denmark In vivo models as predictors of genotoxic carcinogenicity AM CA ML (1853) Model utility (TP - FP) shown by red bars

20DTU Food, Technical University of Denmark In vivo models as predictors of carcinogenicity - Cell transformation SHE (768) Model utility (TP - FP) shown by red bars

21DTU Food, Technical University of Denmark Cluster of SHE/SCE positives

22DTU Food, Technical University of Denmark Activity distribution with Ashby negatives removed

23DTU Food, Technical University of Denmark In vitro results for Ashby positive carcinogens AmesCAMLHGPRTUDSSHE Ames CA ML HGPRT UDS23080 SHE560

24DTU Food, Technical University of Denmark General estimates and in vitro predictions (2140) Ames test918(42.9%) Chromosomal aberrations944(44.1%) Mouse lymphoma982(45.9%) HGPRT496(23.2%) Unscheduled DNA synthesis230(10.7%) Cell transformation (SHE)560(26.2%)

25DTU Food, Technical University of Denmark In vitro mutagens from Ashby positives Predicted positive in Ames test, Mouse lymphoma, or Chromosomal aberrations CHL

26DTU Food, Technical University of Denmark Distribution of in vivo positives (1703) 1703 Genotoxic carcinogens Non- carcinogens Mouse micronucleus Sister chromatid exchange Comet assay Drosophila sex-linked recessive lethal Rodent dominant lethal159741

27DTU Food, Technical University of Denmark Distribution of in vivo positives by percent Genotoxic carcinogens, % Non- carcinogens, % Mouse micronucleus Sister chromatid exchange Comet assay Drosophila sex-linked recessive lethal Rodent dominant lethal9.34.7

28DTU Food, Technical University of Denmark In vivo models as predictors of genotoxic carcinogenicity AM CA ML (1703) Model utility (TP - FP) shown by red bars

29DTU Food, Technical University of Denmark Conclusions: ”Fragment” or ”Rule-Based ” systems provide extremely valuable information, particularly for genotoxic carcinogens In Silico methods could help scientists looking for new fragments or rules Current regulatory use of in vivo tests may need to be modified if they are going to replace carcinogenicity bioassays